Israel’s BioNanoSim (see here previously) is joining forces with Greek-based manufacturer RAFARM, to market BioNanoSim’s eye disease treatments globally. Its product, BNSO-1, is a topical medication that will shortly begin trials on patients suffering from Chronic Anterior Uveitis.

https://nocamels.com/2023/05/eye-disease/

https://www.bionanosim.com/